Last 12 months
Inside the activity.
0 purchase rows · 457 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 47 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 41 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 54 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 33 |
| Jun 2026 | 0 | 68 |
| Jul 2026 | 0 | 47 |
| Aug 2026 | 0 | 33 |
| Sep 2026 | 0 | 59 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2018 Filed Sep 26, 2018 21:33 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 81,914 | $24.95 | $2,044,049.19 |
DisclosureSEC source: 0001179110-18-011678 · edgar.xml · nonDerivative · entry 2 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,528 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.12 to $25.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 24, 2018 Filed Sep 25, 2018 23:17 UTC |
Chapman Steven LeonardChief Operating Officer
|
SaleCommon Stock | 562 | $23.78 | $13,364.02 |
DisclosureSEC source: 0001179110-18-011662 · edgar.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,762 F3 · kind: The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting. Read SEC document |
| September 24, 2018 Filed Sep 25, 2018 23:16 UTC |
Brophy Michael BurkesChief Financial Officer
|
SaleCommon Stock | 446 | $23.78 | $10,605.66 |
DisclosureSEC source: 0001179110-18-011661 · edgar.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671 F3 · kind: The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting. Read SEC document |
| September 24, 2018 Filed Sep 25, 2018 23:16 UTC |
Sheena JonathanDirector · Chief Technology Officer
|
SaleCommon Stock | 324 | $23.78 | $7,704.49 |
DisclosureSEC source: 0001179110-18-011660 · edgar.xml · nonDerivative · entry 2 Sheena Jonathan · CIK 0001646649 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,092 F3 · kind: The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 21:33 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 35,845 | $23.98 | $859,466.32 |
DisclosureSEC source: 0001179110-18-011678 · edgar.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,442 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.58 to $24.34 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2018 Filed Sep 21, 2018 20:44 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 73,173 | $24.14 | $1,766,227.92 |
DisclosureSEC source: 0001179110-18-011610 · edgar.xml · nonDerivative · entry 4 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,287 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.88 to $24.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:17 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011662 · edgar.xml · derivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,173 Underlying: Common Stock · 1,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. F4 · shares: Prior reports inadvertently represented the partial vesting and settlement of Restricted Stock Units as acquired instead of disposed. The number of derivative securities beneficially owned following the reported transaction were correct on all prior reports. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:17 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionCommon Stock | 1,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-011662 · edgar.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018. F2 · price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:16 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011661 · edgar.xml · derivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,173 Underlying: Common Stock · 1,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. F4 · shares: Prior reports inadvertently represented the partial vesting and settlement of Restricted Stock Units as acquired instead of disposed. The number of derivative securities beneficially owned following the reported transaction were correct on all prior reports. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:16 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionCommon Stock | 1,117 | $13.95 | $15,582.15 |
DisclosureSEC source: 0001179110-18-011661 · edgar.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018. F2 · price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:16 UTC |
Sheena JonathanDirector · Chief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011660 · edgar.xml · derivative · entry 3 Sheena Jonathan · CIK 0001646649 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,173 Underlying: Common Stock · 1,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. F4 · shares: Prior reports inadvertently represented the partial vesting and settlement of Restricted Stock Units as acquired instead of disposed. The number of derivative securities beneficially owned following the reported transaction were correct on all prior reports. F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 23:16 UTC |
Sheena JonathanDirector · Chief Technology Officer
|
Exercise / conversionCommon Stock | 1,117 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-011660 · edgar.xml · nonDerivative · entry 1 Sheena Jonathan · CIK 0001646649 · Director · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018. F2 · price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 20:44 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 61,819 | $24.00 | $1,483,841.46 |
DisclosureSEC source: 0001179110-18-011610 · edgar.xml · nonDerivative · entry 3 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,460 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.34 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,288 | $0.00 Strike: $9.59 | $0.00 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · derivative · entry 6 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,712 Underlying: Common Stock · 19,288 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares vest over four years. 25% of the option shares vest and become exercisable on April 1, 2017 and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,712 | $0.00 Strike: $7.45 | $0.00 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · derivative · entry 5 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,793 Underlying: Common Stock · 15,712 shares Expires 2025-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares vest over four years. 25% of the option shares vest and become exercisable on February 16, 2016 and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
SaleCommon Stock | 17,700 | $24.11 | $426,785.94 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · nonDerivative · entry 4 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,207 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.93 to $24.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
SaleCommon Stock | 17,300 | $23.49 | $406,390.84 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · nonDerivative · entry 3 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.93 to $23.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionCommon Stock | 19,288 | $9.59 | $184,971.92 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · nonDerivative · entry 2 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:43 UTC |
Chapman Steven LeonardChief Operating Officer
|
Exercise / conversionCommon Stock | 15,712 | $7.45 | $117,040.26 |
DisclosureSEC source: 0001179110-18-011609 · edgar.xml · nonDerivative · entry 1 Chapman Steven Leonard · CIK 0001711968 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:44 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 16,794 | $24.10 | $404,799.22 |
DisclosureSEC source: 0001179110-18-011610 · edgar.xml · nonDerivative · entry 2 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,153,279 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.92 to $24.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:44 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 60,215 | $23.40 | $1,408,747.99 |
DisclosureSEC source: 0001179110-18-011610 · edgar.xml · nonDerivative · entry 1 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170,073 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.92 to $23.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2018 Filed Sep 18, 2018 21:55 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 62,283 | $24.30 | $1,513,196.63 |
DisclosureSEC source: 0001179110-18-011516 · edgar.xml · nonDerivative · entry 6 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,288 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.78 to $24.70 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 21:55 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 14 | $24.68 | $345.52 |
DisclosureSEC source: 0001179110-18-011516 · edgar.xml · nonDerivative · entry 5 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,292,571 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 21:55 UTC |
Rabinowitz MatthewDirector · Chief Executive Officer
|
SaleCommon Stock | 67,637 | $24.08 | $1,628,827.47 |
DisclosureSEC source: 0001179110-18-011516 · edgar.xml · nonDerivative · entry 4 Rabinowitz Matthew · CIK 0001646382 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,292,585 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for investment diversification purposes on August 10, 2018. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.66 to $24.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 18,125 | $0.00 Strike: $9.59 | $0.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · derivative · entry 11 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 Underlying: Common Stock · 18,125 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option shares vest over four years. 25% of the option shares vest and become exercisable on April 1, 2017 and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 37,983 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · derivative · entry 10 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,267 Underlying: Common Stock · 37,983 shares Expires 2027-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option shares vest over four years. 25% of the option shares vest and become exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · derivative · entry 9 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2025-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options are 100% vested and exercisable. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $9.48 | $0.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · derivative · entry 8 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 22,000 shares Expires 2025-10-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares vest over four years. 25% of the option shares vest and become exercisable on September 4, 2016 and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
SaleCommon Stock | 7,100 | $25.04 | $177,807.43 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 7 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2018. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.97 to $25.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
SaleCommon Stock | 80,297 | $24.50 | $1,967,091.82 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 6 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2018. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.96 to $24.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
SaleCommon Stock | 20,711 | $23.35 | $483,655.70 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 5 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,397 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2018. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.96 to $23.93 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionCommon Stock | 18,125 | $9.59 | $173,818.75 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 4 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionCommon Stock | 37,983 | $10.41 | $395,403.03 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 3 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionCommon Stock | 30,000 | $9.48 | $284,400.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 2 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 21:55 UTC |
Brophy Michael BurkesChief Financial Officer
|
Exercise / conversionCommon Stock | 22,000 | $9.48 | $208,560.00 |
DisclosureSEC source: 0001179110-18-011515 · edgar.xml · nonDerivative · entry 1 Brophy Michael Burkes · CIK 0001697362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:27 UTC |
HEALY JAMESDirector
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011545 · edgar.xml · derivative · entry 2 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 23:27 UTC |
HEALY JAMESDirector
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011545 · edgar.xml · derivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC |
Steuart JohnDirector
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011539 · edgar.xml · derivative · entry 2 Steuart John · CIK 0001646806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC |
Steuart JohnDirector
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011539 · edgar.xml · derivative · entry 1 Steuart John · CIK 0001646806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC |
Cozzens Todd CDirector
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011538 · edgar.xml · derivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC |
Cozzens Todd CDirector
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011538 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:37 UTC |
ROSENMAN HERMDirector
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011535 · edgar.xml · derivative · entry 2 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:37 UTC |
ROSENMAN HERMDirector
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011535 · edgar.xml · derivative · entry 1 ROSENMAN HERM · CIK 0001230057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:35 UTC |
Marcus Gail BoxerDirector
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011533 · edgar.xml · derivative · entry 2 Marcus Gail Boxer · CIK 0001702176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:35 UTC |
Marcus Gail BoxerDirector
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011533 · edgar.xml · derivative · entry 1 Marcus Gail Boxer · CIK 0001702176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:33 UTC |
Baynes Roy D.Director
|
GrantStock Option (right to buy) · Derivative | 16,530 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011531 · edgar.xml · derivative · entry 1 Baynes Roy D. · CIK 0001680739 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,530 Underlying: Common Stock · 16,530 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares vest over three years. A third of the option shares vest and become exercisable on July 25, 2019 and the remaining shares vest on 2 equal annual installments thereafter. The initial option will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:33 UTC |
BOTHA ROELOFDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011529 · edgar.xml · derivative · entry 2 BOTHA ROELOF · CIK 0001222287 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:33 UTC |
BOTHA ROELOFDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011529 · edgar.xml · derivative · entry 1 BOTHA ROELOF · CIK 0001222287 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:33 UTC |
Driscoll Edward C. Jr.Director
|
GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011530 · edgar.xml · derivative · entry 2 Driscoll Edward C. Jr. · CIK 0001646662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:33 UTC |
Driscoll Edward C. Jr.Director
|
GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011530 · edgar.xml · derivative · entry 1 Driscoll Edward C. Jr. · CIK 0001646662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.